Trudy G Oliver
Professor of Pharmacology and Cancer BiologyOverview
The Oliver Lab is focused on understanding the biology of under-studied subtypes of lung cancer, specifically squamous and small cell lung cancer (SCLC). We investigate mechanisms of tumor initiation, progression, plasticity, and drug resistance to uncover vulnerabilities that can be therapeutically targeted. We capitalize on state-of-the-art mouse and patient-derived models to identify and test novel treatment strategies, with the goal of translating these findings to the clinic.
Positions
Professor of Pharmacology and Cancer Biology in the School of Medicine
2023 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2022 School of Medicine
Education
B.S., Oklahoma Baptist University 2001
2001 Oklahoma Baptist University
Ph.D., Duke University 2005
2005 Duke University
Visiting Postdoctoral Research Fellow, University of North Carolina, Chapel Hill, CANCER BIOLOGY 2005 - 2006
2006 University of North Carolina, Chapel Hill
Postdoctoral Fellow, Massachusetts Institute of Technology, CANCER BIOLOGY 2006 - 2011
2011 Massachusetts Institute of Technology
Assistant Professor, University of Utah 2011 - 2017
2017 University of Utah
Associate Professor with Tenure, University of Utah 2017 - 2022
2022 University of Utah
Huntsman Cancer Institute Endowed Chair in Cancer Research, University of Utah 2018 - 2022
2022 University of Utah
Adjunct Associate Professor, University of Utah 2022 - 2023
2023 University of Utah
Publications, Grants & Awards
- Grants (19)
- Awards (3)
- Academics Articles (93)
- Conference Pages (1)
- Book Sections (1)
National Institutes of Health
National Institutes of Health
V Foundation for Cancer Research
National Institute of General Medical Sciences
Memorial Sloan-Kettering Cancer Center
Offices & Contact
308 Research Drive
Durham, NC
27708
Campus Box 3813
Durham, NC
27708